Tissue-non-specific alkaline phosphatase mRNA expression and alkaline phosphatase activity following application of retinoic acid in cultured human dental pulp cells.
Retinoic acid is a potent inducer of tissue-non-specific alkaline phosphatase (TNSALP) expression in various osteoblastic and fibroblastic cells, and may be involved in morphogenesis, cellular growth and differentiation. This study investigates the effects of retinoic acid on alkaline phosphatase activity and TNSALP gene expression in human dental pulp cells. Cultured cells were treated with various concentrations of retinoic acid (0, 10(-7), 10(- 6), 10 (-5) M) in 0.5% bovine serum albumin without serum. Alkaline phosphatase activity was determined by the rate of p-nitrophenyl phosphate hydrolysis and was also assayed in the presence of various inhibitors and under thermal inactivation. A set of specific oligonucleotide primers was selected, based on the nucleotide sequences of two human TNSALP mRNA (bone and liver) types, and reverse transcription-polymerase chain reaction (RT-PCR) performed. Inhibitory and thermal inactivation experiments revealed that the elevated alkaline phosphatase activity had properties of the TNSALP type. RT-PCR showed that retinoic acid enhanced the expression of bone-type TNSALP mRNA in pulp cells. However, the liver-type TNSALP mRNA was not detected. These findings suggest that the high alkaline phosphatase activity of retinoic acid-treated dental pulp cells is associated with increased transcription of the bone-type mRNA of the TNSALP gene and not with liver-type.
San Miguel
S M
SM
Department of Periodontology, Faculty of Dentistry, Tokyo Medical and Dental University, Japan. symone.peri@dent.tmd.ac.jp
Goseki-Sone
M
M
Sugiyama
E
E
Watanabe
H
H
Yanagishita
M
M
Ishikawa
I
I
D000469:Alkaline Phosphatase / Q000032:analysis / Q000096:biosynthesis / Q000187:drug effects* / Q000235:genetics*; D000704:Analysis of Variance; D001483:Base Sequence; D002478:Cells, Cultured; D017931:DNA Primers; D003782:Dental Pulp / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology*; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D012016:Reference Values; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods / Q000706:statistics & numerical data; D013379:Substrate Specificity / Q000187:drug effects; D013997:Time Factors; D014212:Tretinoin / Q000494:pharmacology*
D017931:DNA Primers; D012333:RNA, Messenger; D014212:Tretinoin; D000469:Alkaline Phosphatase